Barbara A. Pockaj, M.D.
Barbara A. Pockaj, M.D., is a surgical oncologist with a strong clinical and research interest in breast cancer and malignant melanoma. Dr. Pockaj's research focuses not only on clinical studies but also translational science. She has an extensive clinical database of newly diagnosed breast and melanoma patients that is coupled with a large complementary biobank of breast cancer specimens.
Several areas of clinical research include clinical behavior of triple negative breast cancers, clinical implications of sentinel lymph node biopsy for breast cancer and melanoma, prognostic significance of palpable breast cancer, and ramifications of breast reconstruction.
Dr. Pockaj is the chair of the Breast Cancer Interest Group (BIG), a collaboration between researchers at the Translational Genomics Research Institute (TGen) and Arizona State University (ASU). The collaboration focuses on using the state-of-the-art genomics infrastructure and a high-quality breast cancer tumor biorepository. The focus of the group is to investigate molecular pathways to identify treatment targets for patients with triple negative breast cancer and endocrine-resistant breast cancer.
Dr. Pockaj's team focuses on:
Other research interests:
Significance to patient care
The treatment of breast cancer has changed from treating it as a single disease to considering tailored treatment as a heterogenous groups of cancers with distinctive pathobiology. The molecular classification of major tumor groups is primarily the result of intensive genomics research. This has significant ramifications for treatment potential. This is true for not only breast cancer but also melanoma.
Leveraging our clinical and translational work is the only way to improve treatment for cancer patients in the future.
Immunotherapy and Surgical Oncology
Electrical and Biomedical Engineering
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.